LoginRegister
    Natco Pharma net profit slips 35pc to Rs 104 crore in Q3Natco Pharma net profit slips 35pc to Rs 104 crore in Q3
    Merck introduces BrightLab, cloud-based instrument connectivity platform for research scientistsMerck introduces BrightLab, cloud-based instrument connectivity platform for research scientists
    Marksans Pharma Farmingdale facility gets Establishment Inspection Report from USFDAMarksans Pharma Farmingdale facility gets Establishment Inspection Report from USFDA
    Coronavirus: Gilead drug remdesivir raises hope for China trialsCoronavirus: Gilead drug remdesivir raises hope for China trials
    CDSCO pulls manufacturers for failing to submit application for category d FDCs; DetailsCDSCO pulls manufacturers for failing to submit application for category d FDCs; Details
    Bayer, Nuvisan ink pact to create new research unit in BerlinBayer, Nuvisan ink pact to create new research unit in Berlin
    NIH-Funded Clinical Trial to test safety of dapivirine vaginal ring, PrEP in pregnant womenNIH-Funded Clinical Trial to test safety of dapivirine vaginal ring, PrEP in pregnant women
    Philips announces DEFINE GPS global multicenter study to assess outcomes of PCI procedures guided by integrated iFR and interventional X-ray imagesPhilips announces DEFINE GPS global multicenter study to assess outcomes of PCI procedures guided by...
    Zydus Cadila gets USFDA nod for bowel disease drug Mesalamine suppositoriesZydus Cadila gets USFDA nod for bowel disease drug Mesalamine suppositories
    Lupin Pithampur unit gets 2 USFDA observationsLupin Pithampur unit gets 2 USFDA observations
    Gazette calls for registrations of medical devices, detailsGazette calls for registrations of medical devices, details
    MEDICREA UNiD IB3D Patient-Matched interbody cages get USFDA clearanceMEDICREA UNiD IB3D Patient-Matched interbody cages get USFDA clearance
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X